144 related articles for article (PubMed ID: 37212971)
1. Prognostic impact of perioperative change in serum p53 antibody titers in esophageal squamous cell carcinoma.
Haneda R; Mayanagi S; Inoue M; Ishii K; Morita Y; Kikuchi H; Hiramatsu Y; Takeuchi H; Tsubosa Y
Esophagus; 2023 Oct; 20(4):669-678. PubMed ID: 37212971
[TBL] [Abstract][Full Text] [Related]
2. Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.
Yamashita K; Makino T; Tanaka K; Yamasaki M; Yamamoto M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2017 Jun; 41(6):1566-1574. PubMed ID: 28108772
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of preoperative serum p53 antibody titers in 1487 patients with surgically treated esophageal squamous cell carcinoma: a multi-institutional study.
Takashi S; Satoshi Y; Akihiko O; Naoya Y; Yusuke T; Kentaro M; Yu O; Yasuaki N; Koichi Y; Takashi F; Ryo O; Isamu H; Chikara K; Kosuke N; Yasuhiro T; Kazuhiko Y; Hideaki S
Esophagus; 2021 Jan; 18(1):65-71. PubMed ID: 32715348
[TBL] [Abstract][Full Text] [Related]
4. Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma.
Shimada H; Shiratori T; Takeda A; Matsushita K; Okazumi S; Akutsu Y; Matsubara H; Nomura F; Ochiai T
World J Surg; 2009 Feb; 33(2):272-7. PubMed ID: 19052812
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma.
Suzuki T; Yajima S; Ishioka N; Nanami T; Oshima Y; Washizawa N; Funahashi K; Otsuka S; Nemoto T; Shimada H
Esophagus; 2018 Oct; 15(4):294-300. PubMed ID: 29959634
[TBL] [Abstract][Full Text] [Related]
6. Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinoma.
Kochi R; Yajima S; Nanami T; Suzuki T; Oshima Y; Tokura N; Takatsuka J; Funahashi K; Tochigi N; Shimada H
Clin J Gastroenterol; 2018 Aug; 11(4):278-281. PubMed ID: 29497977
[TBL] [Abstract][Full Text] [Related]
7. The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma.
Hiyoshi Y; Yoshida N; Watanabe M; Kurashige J; Baba Y; Sakamoto Y; Baba H
World J Surg; 2017 Feb; 41(2):480-486. PubMed ID: 27637603
[TBL] [Abstract][Full Text] [Related]
8. Treatment response and prognosis of patients after recurrence of esophageal cancer.
Shimada H; Kitabayashi H; Nabeya Y; Okazumi S; Matsubara H; Funami Y; Miyazawa Y; Shiratori T; Uno T; Itoh H; Ochiai T
Surgery; 2003 Jan; 133(1):24-31. PubMed ID: 12563234
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
[TBL] [Abstract][Full Text] [Related]
10. Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus.
Kanda M; Koike M; Shimizu D; Tanaka C; Hattori N; Hayashi M; Yamada S; Omae K; Kodera Y
Ann Surg Oncol; 2020 Sep; 27(9):3195-3205. PubMed ID: 32246314
[TBL] [Abstract][Full Text] [Related]
11. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
12. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience.
Lin G; Liu H; Li J
J Cardiothorac Surg; 2019 Mar; 14(1):58. PubMed ID: 30866983
[TBL] [Abstract][Full Text] [Related]
13. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
14. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
[TBL] [Abstract][Full Text] [Related]
15. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
16. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
17. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Intramural Metastasis as an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma.
Ushimaru Y; Makino T; Tanaka K; Yamashita K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Morii E; Eguchi H; Doki Y
Ann Surg Oncol; 2023 Aug; 30(8):5195-5202. PubMed ID: 37273025
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
